Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - Alkermes plc. | alks-20171231ex32158c817.htm |
EX-31.2 - EX-31.2 - Alkermes plc. | alks-20171231ex312d8393e.htm |
EX-31.1 - EX-31.1 - Alkermes plc. | alks-20171231ex311324c03.htm |
EX-23.1 - EX-23.1 - Alkermes plc. | alks-20171231ex231f3952d.htm |
EX-10.17.1 - EX-10.17.1 - Alkermes plc. | alks-20171231ex10171f6a5.htm |
EX-10.10 - EX-10.10 - Alkermes plc. | alks-20171231ex10103cf86.htm |
10-K - 10-K - Alkermes plc. | alks-20171231x10k.htm |
EXHIBIT 21.1
SUBSIDIARIES
Name |
|
Jurisdiction |
|
Alkermes Ireland Holdings Limited |
|
Ireland |
|
Alkermes Pharma Ireland Limited |
|
Ireland |
|
Alkermes Finance Ireland Limited |
|
Ireland |
|
Daravita Pharma Ireland Limited |
|
Ireland |
|
Alkermes Finance Ireland (No. 3) Limited |
|
Ireland |
|
Alkermes Science Four Limited |
|
Ireland |
|
Alkermes Science Five Limited |
|
Ireland |
|
Alkermes Science Six Limited |
|
Bermuda |
|
Daravita Limited |
|
Ireland |
|
Alkermes Finance S.à r.l. |
|
Luxembourg |
|
Alkermes Finance Ireland (No. 2) Limited |
|
Ireland |
|
Alkermes US Holdings, Inc. |
|
Delaware |
|
Alkermes, Inc. |
|
Pennsylvania |
|
Alkermes Controlled Therapeutics, Inc. |
|
Pennsylvania |
|
Alkermes Europe, Ltd. |
|
United Kingdom |
|